UniSa - IRIS Institutional Research Information System

PAPACCIO, Federica
 Distribuzione geografica
Salva come PNG Salva come JPEG
Continente #
AS - Asia 3.680
NA - Nord America 797
EU - Europa 356
SA - Sud America 173
AF - Africa 13
OC - Oceania 5
Continente sconosciuto - Info sul continente non disponibili 1
Totale 5.025
Salva come PNG Salva come JPEG
Nazione #
HK - Hong Kong 3.093
US - Stati Uniti d'America 777
SG - Singapore 389
BR - Brasile 140
RU - Federazione Russa 127
IT - Italia 86
CN - Cina 79
KR - Corea 34
VN - Vietnam 33
DE - Germania 28
IE - Irlanda 27
NL - Olanda 20
GB - Regno Unito 17
AR - Argentina 14
IN - India 11
CA - Canada 10
UA - Ucraina 10
AT - Austria 9
MX - Messico 8
JP - Giappone 7
ID - Indonesia 6
BD - Bangladesh 5
ES - Italia 5
TR - Turchia 5
BE - Belgio 4
CO - Colombia 4
FI - Finlandia 4
PL - Polonia 4
ZA - Sudafrica 4
AU - Australia 3
FR - Francia 3
IQ - Iraq 3
UZ - Uzbekistan 3
VE - Venezuela 3
CL - Cile 2
CZ - Repubblica Ceca 2
DZ - Algeria 2
EC - Ecuador 2
EE - Estonia 2
HU - Ungheria 2
JO - Giordania 2
LK - Sri Lanka 2
PE - Perù 2
PY - Paraguay 2
RO - Romania 2
AM - Armenia 1
AO - Angola 1
AZ - Azerbaigian 1
BO - Bolivia 1
BW - Botswana 1
CR - Costa Rica 1
CW - ???statistics.table.value.countryCode.CW??? 1
DK - Danimarca 1
ET - Etiopia 1
GE - Georgia 1
GT - Guatemala 1
GY - Guiana 1
KE - Kenya 1
KI - Kiribati 1
ML - Mali 1
MR - Mauritania 1
MY - Malesia 1
NA - Namibia 1
NO - Norvegia 1
NP - Nepal 1
NZ - Nuova Zelanda 1
OM - Oman 1
PK - Pakistan 1
RS - Serbia 1
SE - Svezia 1
SR - Suriname 1
TW - Taiwan 1
UY - Uruguay 1
Totale 5.025
Salva come PNG Salva come JPEG
Città #
Hong Kong 3.093
Singapore 184
Dallas 137
Chandler 128
Princeton 95
Ashburn 61
Moscow 53
Dublin 27
Andover 24
Redwood City 23
Wilmington 18
Ann Arbor 15
Naples 15
Amsterdam 13
Ho Chi Minh City 13
Council Bluffs 11
New York 11
Nuremberg 11
Los Angeles 10
San Francisco 9
São Paulo 9
Beijing 8
Seattle 8
Seoul 8
The Dalles 8
Tokyo 7
Hanoi 6
Sarno 6
Vienna 6
Washington 6
Milan 5
Munich 5
Boston 4
Brooklyn 4
Campinas 4
Curitiba 4
Johannesburg 4
Montreal 4
Rome 4
Springfield 4
Warsaw 4
Aprilia 3
Atlanta 3
Brasília 3
Chennai 3
Chicago 3
Columbus 3
Dhaka 3
Duncan 3
Edinburgh 3
González Catán 3
Hangzhou 3
Houston 3
Mexico City 3
New Delhi 3
Norwalk 3
Paris 3
Phoenix 3
Porto Alegre 3
Tashkent 3
Toronto 3
Amman 2
Assago 2
Barbacena 2
Bauru 2
Bourne End 2
Budapest 2
Camaçari 2
Campo Grande 2
Caracas 2
Castellammare di Stabia 2
Concepción 2
Cuiabá 2
Da Nang 2
Ferrara 2
Guarulhos 2
Hải Dương 2
Islington 2
Istanbul 2
Jacksonville 2
Jakarta 2
La Paz 2
Lappeenranta 2
Madrid 2
Manassas 2
Mar del Plata 2
Nova Iguaçu 2
Ostrava 2
Poggiomarino 2
Poplar 2
Pune 2
Resistencia 2
Rio de Janeiro 2
San Jose 2
Santo André 2
The Bronx 2
Topeka 2
Weifang 2
Yubileyny 2
Aalborg 1
Totale 4.206
Salva come PNG Salva come JPEG
Nome #
Mitochondrial transfer from Adipose stem cells to breast cancer cells drives multi-drug resistance 833
Metformin increases antitumor activity of MEK inhibitors through GLI1 downregulation in LKB1 positive human NSCLC cancer cells 701
Adipose Stem Cells and Their Interplay with Cancer Cells and Mitochondrial Reservoir: A New Promising Target 459
The role of chemotherapy in localized and locally advanced rectal cancer: A systematic revision 400
DNA-PK inhibition sustains the antitumor innate immune response in small cell lung cancer 279
Pulmonary Large-Cell Neuroendocrine Carcinoma: From Epidemiology to Therapy 259
Anti-PD1 therapy effects on T cell repertoire and functions in patients with NSCLC cancer: a preliminary study to identify biomarkers of efficacy 115
Role of the Hedgehog pathway in preventing occurrence of resistance to first, second, third generation EGFR-TKIs in first line therapy of NSCLC models with EGFR activating mutations 104
A multicenter, open-label phase II study of metformin with erlotinib in second-line therapy of stage IV non-small-cell lung cancer patients: treatment rationale and protocol dynamics of the METAL trial 88
Decoding chromosomal instability insights in CRC by integrating omics and patient-derived organoids 76
Detection of postoperative plasma circulating tumour DNA and lack of CDX2 expression as markers of recurrence in patients with localised colon cancer 66
Precision Medicine to Treat Advanced Gastroesophageal Adenocarcinoma: A Work in Progress 63
"Proteotranscriptomic analysis of advanced colorectal cancer patient derived organoids for drug sensitivity prediction" 60
Concise Review: Cancer Cells, Cancer Stem Cells, and Mesenchymal Stem Cells: Influence in Cancer Development 57
MiR-423-5p prevents MALAT1-mediated proliferation and metastasis in prostate cancer 56
Implication of the Hedgehog pathway in hepatocellular carcinoma 53
Human primary bone sarcomas contain CD133+ cancer stem cells displaying high tumorigenicity in vivo 53
HDAC2 depletion promotes osteosarcoma's stemness both in vitro and in vivo: a study on a putative new target for CSCs directed therapy 53
Results of the safety run-in part of the METAL (METformin in Advanced Lung cancer) study: a multicentre, open-label phase I-II study of metformin with erlotinib in second-line therapy of patients with stage IV non-small-cell lung cancer 52
Efficacy of osimertinib in combination with Hedgehog pathway inhibitors in reverting T790M-mediated resistence 50
A new inhibitor of glucose-6-phosphate dehydrogenase blocks pentose phosphate pathway and suppresses malignant proliferation and metastasis in vivo 50
HGF/MET and the Immune System: Relevance for Cancer Immunotherapy 50
Molecular profiling of advanced solid tumours. The impact of experimental molecular-matched therapies on cancer patient outcomes in early-phase trials: the MAST study 50
Glucose-6-phosphate dehydrogenase blockade potentiates tyrosine kinase inhibitor effect on breast cancer cells through autophagy perturbation 49
Increased fucosylation has a pivotal role in invasive and metastatic properties of head and neck cancer stem cells 46
Ex vivo lung cancer spheroids resemble treatment response of a patient with NSCLC to chemotherapy and immunotherapy: Case report and translational study 45
Neoadjuvant Chemotherapy in Locally Advanced Rectal Cancer 45
Cancer stem cells in solid tumors: an overview and new approaches for their isolation and characterization 44
SMO Gene Amplification and Activation of the Hedgehog Pathway as Novel Mechanisms of Resistance to Anti-Epidermal Growth Factor Receptor Drugs in Human Lung Cancer 41
PBMCs as Tool for Identification of Novel Immunotherapy Biomarkers in Lung Cancer 39
Prognostic Nutritional Index as an independent prognostic factor in locoregionally advanced squamous cell head and neck cancer 39
In the literature: August 2018 39
Pharmacological targeting of the ephrin receptor kinase signalling by GLPG1790 in vitro and in vivo reverts oncophenotype, induces myogenic differentiation and radiosensitizes embryonal rhabdomyosarcoma cells 39
ZNF518B as a transcriptional factor involved in colorectal cancer progression through the epithelial to mesenchymal transition 38
Circulating cancer stem cells: an interesting niche to explore 38
ITGB1 and DDR activation as novel mediators in acquired resistance to osimertinib and MEK inhibitors in EGFR-mutant NSCLC 32
How organoids can improve personalized treatment in patients with gastro-esophageal tumors 32
Patient-derived organoids as a tool for modelling localized colorectal cancer 32
Efficacy of second and third generation EGFR tyrosine kinase inhibitors, alone or in combination, in T790M-mediated resistance 29
Insulitis in Human Type 1 Diabetic Pancreas: From Stem Cell Grafting to Islet Organoids for a Successful Cell-Based Therapy 28
NK cell receptors in anti-tumor and healthy tissue protection: Mechanisms and therapeutic advances 28
Stemness markers of osteosarcoma 27
Effect of MEK inhibition on PD-L1 and MCH-1 expression and on cytokines production profile in NSCLC cells and in human lymphocites 25
The landscape of combining immune checkpoint inhibitors with novel Therapies: Secret alliances against breast cancer 23
3D patient-derived gastric cancer organoids as a tool for functional precision medicine for gastric cancer patients 23
Urtica dioica L. inhibits proliferation and enhances cisplatin cytotoxicity in NSCLC cells via Endoplasmic Reticulum-stress mediated apoptosis 23
Combined Therapeutic Strategies Based on the Inhibition of Non-Oncogene Addiction to Improve Tumor Response in EGFR- and KRAS-Mutant Non-Small-Cell Lung Cancer 22
Effect of MEK inhibition on PDL1 and and on cytokinesproduction profilein NSCLC cell lines and in human lymphocites 22
Efficacy of sequential treatment with first, second and third generation EGFR inhibitors and role of Hedgehog pathway in the acquisition of resistance in in vivo NSCLC models 22
CNAs concordance between CRC-PDOs and the original tissue reveals relevant oncogenic pathways alterations 22
Role of HGF-MET Signaling in Primary and Acquired Resistance to Targeted Therapies in Cancer. 22
Development of a living organoid biobank derived from colorectal cancer patients: Towards personalized medicine 21
Prognostic nutritional index (PNI) is an independent prognostic factor in locoregionally advanced squamous cell head and neck cancer (LAHNSCC) 20
A novel ImmunoScore, based on clinical and blood biomarkers, as prognostic model for immunotherapy in NSCLC 19
Anti-PD1 therapy effects on T cell repertoire and functions in patients with NSLC cancer: a preliminary study to identify biomarkers of efficacy 19
Will Organoids Fill the Gap towards Functional Precision Medicine? 19
An integrated analysis of gene expression profile and chromosomal aberrations highlighted the oxidative stress role in anti-HER2 drug-resistant gastric cancer models 19
Metastatic colorectal cancer derived organoids recapitulate genomic profile and treatment response of the original tumor 17
New insights from KISS activity: a prognostic biomarker in malignant pleural mesothelioma 17
Antitumoral efficacy of dual blockade of EGFR signaling by osimertinib in combination with selumetinib or cetuximab in activated EGFR human NSCLC tumor models 16
Mutation tracking in circulating tumour DNA (ctDNA) detects minimal residual disease (MRD) in patients with localized colorectal cancer (CRC) and identifies those at high risk of recurrence regardless of stage, lack of CDX2 expression and CMS subtype 15
Reversion of mesenchymal behaviour by AZD9291 (osimertinib) in EGFR mutant NSCLC cell lines resistant to first generation EGFR tyrosine kinase inhibitors 14
Met/Axl system as a dual target in the mesothelioma pathway and invasiveness 14
Results of safety run-in part in Metal (METformin in Advanced Lung cancer) trial 12
Synergistic effect of vismodegib and cisplatin in NSCLC models via autophagy 10
Novel applications of liquid Biopsy: Comprehensive methodology for circulating biomarker exploration in peripheral blood 7
Synergistic effects of oncogene inhibition and pyruvate dehydrogenase kinase blockade in resistant NSCLC cells 4
Totale 5.184
Salva come PNG Salva come JPEG
Categoria #
all - tutte 16.856
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 16.856
Salva come PNG Salva come JPEG


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2020/202168 0 0 0 0 30 13 4 1 5 3 9 3
2021/2022127 3 0 2 0 1 0 0 10 26 0 16 69
2022/2023370 26 0 6 42 46 72 6 52 83 2 30 5
2023/2024202 7 14 10 4 10 34 4 8 28 2 9 72
2024/2025630 8 24 37 17 27 76 107 34 95 40 72 93
2025/20263.762 841 1.388 1.215 79 239 0 0 0 0 0 0 0
Totale 5.184